CXCR4 and breast carcinoma: Besides, the impaired invasive potential due to CXCR4 repression by the treatment of miR-139 in breast cancer cells was confirmed via using short hairpin RNAs (shRNAs) against CXCR4 (sh-CXCR4) (Figure 3A,B).